Alexis Dunham, PharmD, BCPS

Cleveland Clinic Martin Health

Disclosure(s): No financial relationships to disclose

Poster(s):

• 1112 - Evaluating the Effects of Casirivimab-Imdevimab in Mild-to-Moderate COVID-19 Disease: A Matched Cohort Study
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET